期刊文献+

地塞米松干预对不同数目冠状动脉支架植入后高敏C反应蛋白水平的影响 被引量:2

Change study of hsCRP with dexamethasone intervention after different numbers of coronary stent implantation
下载PDF
导出
摘要 目的探讨冠状动脉内植入不同数目支架术后血清高敏C反应蛋白(hsCRP)水平的变化规律及地塞米松对hsCRP水平的影响。方法77例患者随机分为实验组(46例)和对照纽(31例)。实验组植入冠状动脉支架术后立即静脉注射地塞米松10mg;对照组仅植入冠状动脉支架。实验组与对照组每组再分别依据植入支架数目不同分为单杖支架和多枚支架(2~4枚)2个亚组;分别于冠状动脉支架植入术前、术后6小时、12小时、24小时、48小时及72小时留取外周血,检测血清hsCRP值,分组对比研究。结果①实验组术后hsCRP水平与术前比较差异无统计学意义(P〉0.05);对照组术后hsCRP水平与术前比较差异有统计学意义(P〈0.01),hsCRP从术后6小时开始升高,48小时达高峰,持续至72小时开始下降,分别为1.50(3.40)mg/LVS3.10(5.80)mg/L,10.90(17.30)mg/L,6.50(13.80)mg/L(P〈0.01)。两组间比较对照组术后多个时点hsCRP水平高于实验组(均P〈0.01)。②对照组多枚支架和单枚支架亚组术后hsCRP水平与术前比较均升高,但多枚支架亚组术后hsCRP升高更早,幅度更高,持续时间更长。③实验组多枚支架和单枚支架两亚组术后hsCRP与术前比较差异无统计学意义(P〉0.05);两亚组间比较多枚支架亚组于术后多个时点hsCRP水平高于单枚支架亚组(P〈0.05)。结论术后即刻一次静脉应用10mg地塞米松能有效抑制冠状动脉支架植入术后的炎症反应,但对于植入多枚支架患者试图将hsCRP降到理想水平有待进一步探讨。 Objective To investigate changes in serum high-sensitivity C-reactive protein(hsCRP) concentration after different numbers of coronary stent implantation and influence of dexamethasone to hsCRP level. Methods Seventy-seven cases of patients were randomly divided into experimental group( n = 46) and control group (n = 31). Experimental group was immediately intravenously injected dexamethasone 10 mg after stent implantation; the control group got only coronary stent implantation. Both groups were re-divided into sub-groups based on the number of different stent implantation including single and muhi-stent(2-4) pieces of stent,respectively. Samples of venous serum in all groups were obtained to determine the hsCRP concentration before stent implantation and 6 h, 12 h, 24 h, 48 h, 72 h after stent implantation for comparative study. Results ①Compared with the preoperative hsCRP values,there were no significant differences within experimental group at each time point after stenting( P 〉0.05). Compared with the preoperative values, the hsCRP in control groups 6 hours after stenting began to increase,48 hours reached a peak, 72 hours began to decrease,1.50(3.40) mg/L vs 3.10(5.80) rag/L,10.90(17.30) mg/L,6. 50(13. 80) mg/L,there were significant differences ( P 〈 0.01 ). There were significant differences in hsCRPs values between experimental and control groups after stenting(all P 〈0.01), the level of hsCRP in control group was higher than that of experimental group multiple points after stenting. ②Compared with the preoperative, the hsCRP value after stenting in two subgroups of control groups all were increased, there were significant differences( P 〈0.05). hsCRP after stenting increased earlier, showed higher concentration,longer duration in multi-stent sub-group. ③ Respectively compared with the preoperative hsCRP values,there were no significant differences within two sub-groups of experimental group after stenting( P 〉0.05). There were significant differences in hsCRP values between two sub-groups( P 〈0.05) ,the level of hsCRP in multi-stent subgroup was higher than single stent subgroup at multiple points after stenting. Conclusion Immediately one time intravenous injection of dexamethasone 10 mg after stenting can effectively inhibit the inflammatory reaction after coronary stent implantation, however, the attempt of more than one stent implantation patients' hsCRP down to desired level will be further explored.
作者 张颖 刘晓桥
出处 《临床荟萃》 CAS 2010年第5期386-389,共4页 Clinical Focus
关键词 血管成形术 经腔 经皮冠状动脉 冠状动脉疾病 C反应蛋白质 地塞米松 angioplasty, transluminal, percutaneous coronary coronary disease C-reactive protein dexamethasone
  • 相关文献

参考文献9

  • 1李晓涛,夏岳.炎症反应在冠脉支架置入术后再狭窄中的研究进展[J].心血管病学进展,2007,28(5):703-706. 被引量:12
  • 2高润霖,刘冰.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2002,30(12):707-718. 被引量:335
  • 3Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia[J]. J Am Coll Cardiol, 1998,31 ( 1 ) : 224- 230.
  • 4Versaei F, Gaspardone A, Tomai F, et al. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study)[J]. J Am Coil Cardiol, 2002,40(11) :1935-1942.
  • 5王建波,杨建勇,陈伟,庄文权,张珑涓,李家平.地塞米松对血管内支架介入术后再狭窄作用的实验研究[J].介入放射学杂志,2007,16(3):194-197. 被引量:6
  • 6Li JJ, Fang CH,Jiang H, et al. Time course of inflammatory response after renal artery stenting in patients with atheroselerotic renal artery stenosis[J]. Clin Chim Acta, 2004, 350(1/2):115-121.
  • 7Li J J, Qin XW, Yang XC, et al. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions [J]. Clin Chim Acta,2008,396(1/2) :38-42.
  • 8Yeh ET, Anderson HV, Pasceri V, et al. C-reactive protein linking inflammation to cardiovascular complications [J ]. Circulation, 2001,104 (9) : 974-975.
  • 9国家药典委员会.临床用药须知,化学和生物制品卷.中华人民共和国药典[M].北京:人民卫生出版社,2005:443.

二级参考文献40

  • 1王永利,李明华.血管发生学与PTA后血管壁细胞来源[J].介入放射学杂志,2006,15(1):57-59. 被引量:2
  • 2Petrik PV,Law MM,Moore WS,et al.Dexamethasone and enalapril suppress intimal hyperplasia individually but have no synergistic effect[J].Ann Vasc Surg,1998,12:216-220.
  • 3Rhee K,Bresnahan W,Hirai A,et al.c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation[J].Cancer Res,1995,55:4188-4195.
  • 4Fernandes D,Guida E,Koutsoubos V,et al.Glucocorticoids inhibit proliferation,cyclin D1 expression,and retinoblastoma protein phosphorylation,but not activity of the extracellularregulated kinases in human cultured airway smooth muscle[J].Am J Respir Cell Mol Biol,1999,21:77-88.
  • 5Simons M,Edelman ER,Rosenberg RD.Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model[J].J Clin Invest,1994,93:2351-2356.
  • 6Pellicciari C,Danova M,Giordano M,et al.Expression of cell cycle related proteins-proliferating cell nuclear antigen (PCNA)and statin-during adaptation and de-adaptation of EUE cells to a hypertonic medium[J].Cell Prolif,1991,24:469-479.
  • 7Goswami PC,Albee LD,Spitz DR,et al.A polymerase chain reaction assay for simultaneous detection and quantitation of proto-oncogene and GAPD mRNAs in different cell growth rates[J].Cell Prolif,1997,30:271 -282.
  • 8Kornowski R,Hong MK,Tio FO,et al.In-stent restenosis:contributions of inflammatory responses and arterial injury to neointimal hyperplasia[J].J Am Coll Cardiol,1998,31:224 -230.
  • 9Suzuki T,Kopia G,Hayashi S,et al.Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model[J].Circulation,2001,104:1188-1193.
  • 10Lincoff AM,Furst JG,Ellis SG,et al.Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model[J].J Am Coll Cardiol,1997,29:808-816.

共引文献350

同被引文献34

  • 1胡信群,方臻飞,沈向前,周胜华,祁述善,刘启明.塞来昔布短期治疗对冠状动脉支架植入术患者hsCRP的影响[J].医学临床研究,2005,22(6):780-782. 被引量:1
  • 2Radke PW,Kaiser A,Frost C,et al.Outcome after treatment of coronary in stent restenosis results from a systematic review using meta-analysis t echniques.Eur Heart J.2003;24(3):266-273.
  • 3Wang Y,Wang VM,Chan CC.The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.Eye (Lond).2011;25(2):127-139.
  • 4Huang Y,Venkatraman SS,Boey FY,et al.In vitro and in vivo performance of a dual drug-eluting stent (DDES).Biomaterials.2010;31(15):4382-4391.
  • 5Boskabady MH,Vahedi N,Amery S,et al.The effect of Nigella sativa alone,and in combination with dexamethasone,on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigs.J Ethnopharmacol.2011;137(2):1028-1034.
  • 6Palma L,Sfara C,Antonelli A,et al.Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages.2011;11(1):5217-5226.
  • 7Burns KE,Chant C,Smith O,et al.A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists-Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT):study protocol and design of a randomized controlled trial.Trials.2011;3(9):12:70.
  • 8Ridker PM,Silvertown JD.Inflammation,C-reactive protein,and atherothrombosis.J Periodontol.2008;79(8 Suppl):1544-1551.
  • 9Bailar JC 3rd.The promise and problems of meta-analysis.N Engl J Med.1997;337(8):559-561.
  • 10乐杰.妇产科学[M].8版.北京:人民卫生出版社,2011:356.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部